Lite Strategy

LITSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$40.810 M

$1.28 +13.27%

Close of 21 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$15.9M

Loss-making

Shares outstanding

34,025,200

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#363VeruVERU$41.6M
#364Seres TherapeuticsMCRB$40.9M
#365Lite StrategyLITS$40.8M
#366Nasus PharmaNSRX$40.3M
#367Actinium PharmaceuticalsATNM$37.7M

What if Lite Strategy were worth as much as…

Open the what-if tool →

Gold $30.3T

$949,546.43

Per share 741,833× higher

Bitcoin $1.72T

$53,941.68

Per share 42,142× higher

Nvidia $5.48T

$171,875.88

Per share 134,278× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for Lite Strategy are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.